Growth factors, in particular vascular endothelial growth factor [62] and insulin-like growth factor-1 [63], have shown promise as neuroprotective agents in murine models of familial ALS and if PGRN is neurotrophic for motor neurons [25] it could also have therapeutic potential in ALS. Here, GRN is linked to amyotrophic lateral sclerosis.